Related Experiment Video
Updated: Dec 29, 2025

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Diabetes Mellitus and Acute Myocardial Infarction: Impact on Short and Long-Term Mortality
Valentina Milazzo1, Nicola Cosentino1, Stefano Genovese1
1Centro Cardiologico Monzino IRCCS, Milan, Italy.
Abstract:
Diabetes mellitus (DM) is an important risk factor for acute myocardial infarction (AMI) and a frequent co-morbidity in patients hospitalized with AMI, being present in about 30% of cases. Although current treatment of AMI has considerably improved survival in both patients with and without DM, the presence of DM still doubles the case fatality rate during both the acute phase of AMI and at long-term follow-up. This higher mortality risk of DM patients strongly indicates a particular need for better treatment options in these patients and suggests that intensive medical treatment, prolonged surveillance, and stringent control of other risk factors should be carefully pursued and maintained for as long as possible in them.In this review, we will focus on the close association between DM and in-hospital and long-term mortality in AMI patients. We will also aim at providing current evidence on the mechanisms underlying this association and on emerging therapeutic strategies, which may reduce the traditional mortality gap that still differentiates AMI patients with DM from those without.
Insights
Diabetes mellitus (DM) significantly increases mortality risk in acute myocardial infarction (AMI) patients. New therapeutic strategies are needed to reduce this gap and improve survival for diabetic individuals experiencing heart attacks.
Area of Science:
- Cardiology
- Endocrinology
- Public Health
Background:
- Diabetes mellitus (DM) is a major risk factor for acute myocardial infarction (AMI).
- DM affects approximately 30% of patients hospitalized with AMI.
- Diabetic patients with AMI face double the case fatality rate compared to non-diabetic patients.
Purpose of the Study:
- To review the association between DM and mortality in AMI patients.
- To explore the underlying mechanisms of this increased mortality.
- To present emerging therapeutic strategies for reducing mortality in diabetic AMI patients.
Main Methods:
- Literature review focusing on DM and AMI outcomes.
- Analysis of current evidence on pathophysiological mechanisms.
- Evaluation of novel and existing treatment approaches.
Main Results:
- DM presence doubles mortality risk in AMI patients during acute and long-term phases.
- Specific mechanisms linking DM and increased AMI mortality are discussed.
- Emerging therapies show potential in bridging the mortality gap.
Conclusions:
- Diabetic patients with AMI require intensified medical management and risk factor control.
- Further research into targeted therapies is crucial for improving outcomes.
- Reducing the mortality gap in diabetic AMI patients remains a critical clinical challenge.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
Related Concept Videos
Coronary Artery Disease I: Introduction
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Myocarditis I: Introduction
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease III: Clinical Manifestations